Paper8538748
Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours.
Graeber TG and 6 others. Nature, 1996. Cited by 2,051 papers, by iCite.
Cite this record
ConductScience Library. Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours. Papers, record 8538748. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/8538748
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics16
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Apoptosis | Major topic |
| Neoplasms | Major topic |
| Oxygen | Major topic |
| Animals | |
| Cell Hypoxia | |
| Cell Line, Transformed | |
| Cell Transformation, Neoplastic | |
| Genes, p53 | |
| Mice | |
| Neoplasm Transplantation | |
| Proto-Oncogene Proteins | |
| Proto-Oncogene Proteins c-bcl-2 | |
| Proto-Oncogene Proteins c-myc | |
| Rats | |
| Receptors, Estrogen | |
| Tamoxifen |
Source PubMed
Comments and corrections2
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers | Source |
|---|---|---|---|---|
| Comment in | 8538735 | Life (and death) in a malignant tumour. | https://conductscience.org/library/papers/8538735 | PubMed |
| Comment in | 8600376 | Little difference. | https://conductscience.org/library/papers/8600376 | PubMed |
Cited by656
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 2,051 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42506076 | Neuromodulation in Neuro-Oncology: A Scoping Review. | J Pers Med | 2026 | https://conductscience.org/library/papers/42506076 | PubMed |
| 42286021 | Endoglin (CD105) overexpression is associated with an immunosuppressive tumor microenvironment in murine lung cancer models and human lung adenocarcinoma. | Sci Rep | 2026 | https://conductscience.org/library/papers/42286021 | PubMed |
| 41900967 | Pathogenic Mechanisms in Cervical Cancer: Energy Metabolism, Hypoxia and Therapy. | Life (Basel) | 2026 | https://conductscience.org/library/papers/41900967 | PubMed |
| 41898553 | The Significance of CXCL1 in Cancer: An Overview of Molecular Mechanisms. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/41898553 | PubMed |
| 41526628 | Prognostic Value of Preoperative Anemia on Survival and Recurrence in Patients with Bladder Carcinoma Treated by Radical Cystectomy. | Ann Surg Oncol | 2026 | https://conductscience.org/library/papers/41526628 | PubMed |
| 41369841 | Breast Cancer Progression by the FGF/FGFR Axis: A Metabolic Perspective. | J Mammary Gland Biol Neoplasia | 2025 | https://conductscience.org/library/papers/41369841 | PubMed |
| 41171287 | ROSBASE1.0: a comprehensive database of reactive oxygen species (ROS): categorization of cell organelles, proteins, taxonomy, and diseases based on ROS-related activities. | Database (Oxford) | 2025 | https://conductscience.org/library/papers/41171287 | PubMed |
| 41057692 | A cellular and spatial atlas of TP53-associated tissue remodeling defines a multicellular tumor ecosystem in lung adenocarcinoma. | Nat Cancer | 2025 | https://conductscience.org/library/papers/41057692 | PubMed |
| 40964288 | Tumor nutrient stress gives rise to a drug tolerant cell state in pancreatic cancer. | bioRxiv | 2025 | https://conductscience.org/library/papers/40964288 | PubMed |
| 40447954 | Tumor hypoxia shapes natural killer cell anticancer activities. | J Mol Med (Berl) | 2025 | https://conductscience.org/library/papers/40447954 | PubMed |
| 40005071 | Coenzyme Q10 as an Inhibitor of Effector Release from One-Electron-Reduced Bioreductive Anticancer Prodrugs. | Molecules | 2025 | https://conductscience.org/library/papers/40005071 | PubMed |
| 39966387 | Long-term adaptation of lymphoma cell lines to hypoxia is mediated by diverse molecular mechanisms that are targetable with specific inhibitors. | Cell Death Discov | 2025 | https://conductscience.org/library/papers/39966387 | PubMed |
| 39875616 | Tumour hypoxia in driving genomic instability and tumour evolution. | Nat Rev Cancer | 2025 | https://conductscience.org/library/papers/39875616 | PubMed |
| 39682147 | Machine Perfusion as a Strategy to Decrease Ischemia-Reperfusion Injury and Lower Cancer Recurrence Following Liver Transplantation. | Cancers (Basel) | 2024 | https://conductscience.org/library/papers/39682147 | PubMed |
| 39627312 | An innovative cellular medicine approach via the utilization of novel nanotechnology-based biomechatronic platforms as a label-free biomarker for early melanoma diagnosis. | Sci Rep | 2024 | https://conductscience.org/library/papers/39627312 | PubMed |
| 39236027 | Identifying crucial lncRNAs and mRNAs in hypoxia-induced A549 lung cancer cells and investigating their underlying mechanisms via high-throughput sequencing. | PLoS One | 2024 | https://conductscience.org/library/papers/39236027 | PubMed |
| 39201609 | Disclosing the Novel Protective Mechanisms of Ocrelizumab in Multiple Sclerosis: The Role of PKC Beta and Its Down-Stream Targets. | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/39201609 | PubMed |
| 38697993 | NREP, transcriptionally upregulated by HIF-1α, aggravates breast cancer cell growth and metastasis by promoting glycolysis. | Cell Death Discov | 2024 | https://conductscience.org/library/papers/38697993 | PubMed |
| 38487001 | Targeting the Warburg effect: A revisited perspective from molecular mechanisms to traditional and innovative therapeutic strategies in cancer. | Acta Pharm Sin B | 2024 | https://conductscience.org/library/papers/38487001 | PubMed |
| 38398017 | Current and Emerging Diagnostic, Prognostic, and Predictive Biomarkers in Head and Neck Cancer. | Biomedicines | 2024 | https://conductscience.org/library/papers/38398017 | PubMed |
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| BCL2 | 596 | PubTator's text mining | https://conductscience.org/library/genes/596 | NCBI Gene |
| TP53 | 7157 | PubTator's text mining | https://conductscience.org/library/genes/7157 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/8538748
GET https://conductscience.org/api/papers/v1/8538748/cited_by?page=2